Pierre Chrétien

3.3k total citations · 1 hit paper
49 papers, 2.9k citations indexed

About

Pierre Chrétien is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Pierre Chrétien has authored 49 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Surgery. Recurrent topics in Pierre Chrétien's work include Heat shock proteins research (12 papers), Protein Structure and Dynamics (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Pierre Chrétien is often cited by papers focused on Heat shock proteins research (12 papers), Protein Structure and Dynamics (5 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Pierre Chrétien collaborates with scholars based in France, Canada and United States. Pierre Chrétien's co-authors include Jacques Landry, Herman Lambert, L A Weber, Eileen Hickey, Shi‐Hsiang Shen, Barry I. Posner, Lison Bastien, Robert M. Tanguay, Louis M. Nicole and Normand Marceau and has published in prestigious journals such as Nature, The Lancet and Nucleic Acids Research.

In The Last Decade

Pierre Chrétien

47 papers receiving 2.8k citations

Hit Papers

Heat shock resistance conferred by expression of the huma... 1989 2026 2001 2013 1989 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Chrétien France 22 2.2k 499 362 361 351 49 2.9k
Michael Tytell United States 31 2.5k 1.2× 175 0.4× 958 2.6× 601 1.7× 739 2.1× 74 3.6k
Mitsuaki Fujimoto Japan 31 2.7k 1.3× 322 0.6× 850 2.3× 375 1.0× 204 0.6× 61 3.4k
B. Koch United States 16 2.4k 1.1× 192 0.4× 388 1.1× 524 1.5× 602 1.7× 34 3.0k
Irina V. Guzhova Russia 29 1.9k 0.9× 173 0.3× 443 1.2× 415 1.1× 199 0.6× 120 2.6k
Anatoli B. Meriin United States 25 2.9k 1.4× 140 0.3× 930 2.6× 471 1.3× 656 1.9× 35 3.6k
Elisabeth Christians France 31 2.4k 1.1× 168 0.3× 480 1.3× 384 1.1× 91 0.3× 61 3.0k
D. Randy McMillan United States 15 1.5k 0.7× 156 0.3× 431 1.2× 257 0.7× 165 0.5× 18 2.0k
Mario D. Galigniana Argentina 42 3.7k 1.7× 151 0.3× 510 1.4× 331 0.9× 257 0.7× 102 5.0k
L Lim United Kingdom 27 1.7k 0.8× 70 0.1× 460 1.3× 264 0.7× 331 0.9× 74 2.5k
Eiichi Takaki Japan 24 1.1k 0.5× 138 0.3× 367 1.0× 208 0.6× 111 0.3× 33 1.8k

Countries citing papers authored by Pierre Chrétien

Since Specialization
Citations

This map shows the geographic impact of Pierre Chrétien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Chrétien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Chrétien more than expected).

Fields of papers citing papers by Pierre Chrétien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Chrétien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Chrétien. The network helps show where Pierre Chrétien may publish in the future.

Co-authorship network of co-authors of Pierre Chrétien

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Chrétien. A scholar is included among the top collaborators of Pierre Chrétien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Chrétien. Pierre Chrétien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chrétien, Pierre, et al.. (2012). Maximal wild monodromy in unequal characteristic. Journal of Number Theory. 133(4). 1389–1408.
2.
Chrétien, Pierre, et al.. (2002). Alfuzosin, an a1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia: once daily versus 3 times daily dosing in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 40(7). 289–294. 14 indexed citations
3.
Johanet, Catherine, C. André, Jean Sibilia, et al.. (2000). Signification clinique des anticorps antiribosomes. La Revue de Médecine Interne. 21(6). 510–516. 16 indexed citations
4.
Canal, M., et al.. (1998). Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers. European Journal of Clinical Pharmacology. 54(5). 405–409. 31 indexed citations
5.
Fillastre, J P, M. Godin, B. Legallicier, et al.. (1996). Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairment. Journal of Antimicrobial Chemotherapy. 37(5). 965–974. 10 indexed citations
6.
Chrétien, Pierre, et al.. (1996). Description of a modified sequencing strategy and the molecular characterization of HLA‐B*8201. Tissue Antigens. 47(5). 438–441. 11 indexed citations
7.
Chrétien, Pierre, et al.. (1994). Cosegregation of Hirschsprung`s disease (HSCR) and a RET mutation in a French Canadian family with MEN 2A. The American Journal of Human Genetics. 55. 5 indexed citations
8.
Sandouk, P., et al.. (1994). Single‐dose bioavailability of oral and intramuscular thiocolchicoside in healthy volunteers. Biopharmaceutics & Drug Disposition. 15(1). 87–92. 15 indexed citations
9.
Coquerel, Antoine, et al.. (1993). Pooling plasmas for a rapid answer in pharmacokinetic studies: application to a bioequivalence study of hydrocortisone tablets. Fundamental and Clinical Pharmacology. 7(5). 253–260. 7 indexed citations
10.
Shen, Shi‐Hsiang, Lison Bastien, Barry I. Posner, & Pierre Chrétien. (1991). A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases. Nature. 352(6337). 736–739. 366 indexed citations
11.
Billaud, Eliane M., R. Guillemain, Nicolas Fortineau, et al.. (1990). Interaction Between Roxithromycin and Cyclosporin in Heart Transplant Patients. Clinical Pharmacokinetics. 19(6). 499–502. 21 indexed citations
12.
Chrétien, Pierre, et al.. (1990). Sequence of the Chinese hamster small heat shock protein HSP27. Nucleic Acids Research. 18(6). 1637–1637. 24 indexed citations
13.
Gouyon, Jean‐Bernard, et al.. (1990). Pharmacokinetics of Cefotaxime in Preterm Infants. Developmental Pharmacology and Therapeutics. 14(1). 29–34. 16 indexed citations
14.
Aujard, Y., et al.. (1989). Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn. Diagnostic Microbiology and Infectious Disease. 12(1). 87–91. 17 indexed citations
15.
Johanet, Catherine, et al.. (1989). [Antinuclear antibodies in primary biliary cirrhosis].. PubMed. 13(8-9). 690–5. 3 indexed citations
16.
Chrétien, Pierre & Jacques Landry. (1988). Enhanced constitutive expression of the 27‐kDa heat shock proteins in heat‐resistant variants from chinese hamster cells. Journal of Cellular Physiology. 137(1). 157–166. 117 indexed citations
17.
Daoust, Martine, Nicholas Moore, Christian Saligaut, et al.. (1986). Striatal dopamine does not appear involved in the voluntary intake of ethanol by rats. Alcohol. 3(1). 15–17. 10 indexed citations
18.
Boismare, F, et al.. (1985). Hemodynamic, behavioral and biochemical disturbances induced by an experimental cranio-cervical injury (whiplash) in rats. Journal of the Autonomic Nervous System. 13(2). 137–147. 9 indexed citations
19.
Daoust, Martine, et al.. (1984). Attenuation by antidepressant drugs of alcohol intake in rats. Alcohol. 1(5). 379–383. 46 indexed citations
20.
Moore, Nicholas, Bruno Gügi, Christian Saligaut, et al.. (1983). The Effects of Nicergoline on Spontaneously Hypertensive Rats and Their Offspring. Clinical and Experimental Hypertension Part A Theory and Practice. 5(4). 613–624. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026